Implementing SGLT2 Inhibitors in Cardiovascular–Kidney–Metabolic (CKM) Syndrome: A Multidisciplinary Expert Perspective

Key Points

• The research aims to outline the importance of integrating SGLT2 inhibitors in managing cardiovascular-kidney-metabolic syndrome.
• Identified the need for a proactive management approach to CKM syndrome.
• Proposed a multidisciplinary coordination model among various medical specialties.
• Emphasized the establishment of clinical algorithms for early interventions.
• SGLT2 inhibitors should be viewed as foundational, disease-modifying therapies.
• Improved patient outcomes are expected through better integration of care.
• Clear communication strategies can enhance understanding and adherence to interventions.

Structured PICO

Abstract